These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28301792)

  • 1. Systemic lupus erythematosus: an update.
    Golder V; Hoi A
    Med J Aust; 2017 Mar; 206(5):215-220. PubMed ID: 28301792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.
    Medina-Rosas J; Al-Rayes H; Moustafa AT; Touma Z
    Expert Opin Biol Ther; 2016 Oct; 16(10):1225-38. PubMed ID: 27429254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A; Tziolos N; Bertsias G; Boumpas DT
    Ann Rheum Dis; 2021 Jan; 80(1):14-25. PubMed ID: 33051219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic Lupus Erythematosus (SLE) - New Classification Criteria].
    Aringer M; Dörner T
    Dtsch Med Wochenschr; 2018 Jun; 143(11):811-814. PubMed ID: 29807382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten developments in the use of biologicals for systemic lupus erythematosus.
    Wallace DJ
    Curr Rheumatol Rep; 2013 Jul; 15(7):337. PubMed ID: 23666467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS; Reimold AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].
    Ramos-Casals M; Ruiz-Irastorza G; Jiménez-Alonso J; Khamashta MA;
    Rev Clin Esp (Barc); 2013; 213(1):42-58. PubMed ID: 23266125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany].
    Mucke J; Aringer M
    Z Rheumatol; 2024 Aug; 83(6):431-438. PubMed ID: 39037547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus diagnosis and management.
    Thong B; Olsen NJ
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i3-i13. PubMed ID: 28013206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belimumab: targeted therapy for lupus.
    Chugh PK; Kalra BS
    Int J Rheum Dis; 2013 Feb; 16(1):4-13. PubMed ID: 23441766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Staveri C; Karokis D; Liossis SC
    Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Treatments in Lupus.
    Kyttaris VC
    Curr Rheumatol Rep; 2017 Mar; 19(3):10. PubMed ID: 28265845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
    Nakayama K; Tamimoto Y; Nakayama T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on belimumab for the management of systemic lupus erythematosus.
    Lutalo PM; D'Cruz DP
    Expert Opin Biol Ther; 2014 Nov; 14(11):1701-8. PubMed ID: 25303323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic avenues in SLE.
    Bakshi J; Ismajli M; Rahman A
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):794-809. PubMed ID: 27107514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.